Article

phillymag.comphillymag.com on 2021-05-26 18:16

NextUp: The Philly Biotech Company Developing an In Vivo Approach to CAR T-Cell Therapy

Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing of in vivo CAR T therapy.

Related news